SC
INBX icon

Slotnik Capital’s Inhibrx INBX Stock Holding History

Slotnik Capital’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-41,401
Closed -$1.39M – 42
2025
Q3 		$1.39M Sell
41,401
-142,770
-78% -$3.51M 0.44% 26
2025
Q2 		$2.63M Sell
184,171
-102,791
-36% -$1.33M 1% 18
2025
Q1 		$4.01M Sell
286,962
-101,038
-26% -$1.37M 1.94% 11
2024
Q4 		$5.98M Buy
388,000
+18,646
+5% +$284K 2.7% 12
2024
Q3 		$5.78M Buy
369,354
+27,749
+8% +$390K 1.92% 17
2024
Q2 		$4.84M Buy
+341,605
New +$5.34M 2.35% 13

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Slotnik Capital's INBX Position: Q4 2025 in Review

Slotnik Capital sold out of Inhibrx (INBX) in Q4 2025, closing a stake of 41,401 shares — an estimated $1.39M sold.

Slotnik Capital first reported a position in INBX in Q2 2024 and held it in 6 quarters. The position peaked at $5.98M in Q4 2024. 138 funds tracked by Wall St. Rank hold INBX as of Q4 2025.

  • Slotnik Capital reported no remaining Inhibrx position as of Q4 2025 after selling out during the quarter.
  • Slotnik Capital sold 41,401 Inhibrx shares in Q4 2025, an estimated $1.39M.
  • Slotnik Capital first reported a position in Inhibrx in Q2 2024 and held it in 6 quarters.
  • Slotnik Capital's Inhibrx position peaked at $5.98M in Q4 2024.
  • 138 funds tracked by Wall St. Rank held Inhibrx as of Q4 2025.

Based on Slotnik Capital's 13F filing for Q4 2025, filed 13 Feb 2026.